Lee's Pharm.
|
About Lee's Pharm.
|
Lee's Pharm Products
|
Media
|
Careers at Lee's Pharm.
|
Contact Lee's Pharm.
|
A Professional Website Design Company
Clinical Trials | Lee's Pharmaceutical
About Us
Corporate Overview
Corporate Governance
Board of Directors
Committee Members
Key Personnel
Memorandum and Articles of Association
Procedures for a shareholder to propose a person for election as a director
Group Chart
Milestones and Awards
Timeline of Launched Products
Manufacturing Sites
Licensing and Partnership
Products
Greater China Market
Drug Safety Information
R&D
Key Focus Area
Product Pipeline
Clinical Trials
Medical Frontiers
Lee’s Pharm Genomics Lab
News & Media
Recent News and Release
Archive
Investor Relations
Fact Sheet
Trading Information
Financial Highlights
Announcements and Circulars
Financial Reports
Environmental, Social and Governance Reports
Corporation Information
Stock Price Information
People
Contact Us
繁體
简体
About Us
Corporate Overview
Corporate Governance
Board of Directors
Committee Members
Key Personnel
Memorandum and Articles of Association
Procedures for a shareholder to propose a person for election as a director
Group Chart
Milestones and Awards
Timeline of Launched Products
Manufacturing Sites
Licensing and Partnership
Products
Greater China Market
Drug Safety Information
R&D
Key Focus Area
Product Pipeline
Clinical Trials
Medical Frontiers
Lee’s Pharm Genomics Lab
News & Media
Recent News and Release
Archive
Investor Relations
Fact Sheet
Trading Information
Financial Highlights
Announcements and Circulars
Financial Reports
Environmental, Social and Governance Reports
Corporation Information
Stock Price Information
People
Contact Us
Home
>
R & D
>
Clinical Trials
Research and Development
Clinical Trials
Ongoing Clinical Trial Project Summary
Extensive Stage Small Cell Lung Cancer
Phase Ib Study of Recombinant Anti-PD-L1 Monoclonal Antibody Injection (ZKAB001) Combined With Carboplatin and Etoposide in the Treatment of Extensive Small Cell Lung Cancer
Company
China Oncology Focus Limited
Therapeutic Area
Oncology
Product
ZKAB001
Phase
Ib
Official Study Title
Phase Ib Study of Recombinant Anti-PD-L1 Monoclonal Antibody Injection (ZKAB001) Combined With Carboplatin and Etoposide in the Treatment of Extensive Small Cell Lung Cancer
ClinicalTrials.gov Identifier
NCT04346914
#of Sites
3
#of Patients
20
Status
Recruiting
Link
Cervical Cancer
Phase III Study of Socazolimab as First-Line Treatment in Persistent, Recurrent, or Metastatic Cervical Cancer
Company
China Oncology Focus Limited
Therapeutic Area
Oncology
Product
Socazolimab
Phase
III
Official Study Title
Phase III Study of Socazolimab as First-Line Treatment in Persistent, Recurrent, or Metastatic Cervical Cancer
ClinicalTrials.gov Identifier
NCT06459687
#of Sites
47
#of Patients
440
Status
recruiting
Link
Glioma
Phase III Clinical Trial Evaluating the Efficacy and Safety of 5-aminolevulinic Acid (5-ALA）
Company
Lee's Pharmaceutical Limited
Therapeutic Area
Oncology
Product
5-aminolevulinic Acid
Phase
III
Official Study Title
Phase III Clinical Trial Evaluating the Efficacy and Safety of 5-aminolevulinic Acid (5-ALA）
ClinicalTrials.gov Identifier
NCT06160492
#of Sites
8
#of Patients
144
Status
recruiting
Link
Advanced Hepatocellular Carcinoma
Study of AU409 Capsule in Advanced Hepatocellular Carcinoma Patients Who Failed Standard Treatment
Company
Lee's Pharmaceutical Limited
Therapeutic Area
Oncology
Product
AU409
Phase
I
Official Study Title
Study of AU409 Capsule in Advanced Hepatocellular Carcinoma Patients Who Failed Standard Treatment
ClinicalTrials.gov Identifier
NCT06374485
#of Sites
1
#of Patients
18
Status
recruiting
Link
